Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you

recruiting
3 975
countries
28
conditions
2 106

5 trials match your criteria

Gaucher's disease type III

Not yet recruiting

Efficacy and safety of oral venglustat versus intravenous imiglucerase in children aged 2‑11 years with Gaucher disease type 3

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Imiglucerase

Fabry's disease

Not recruiting

Study comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Agalsidase beta

Gaucher's disease type III

Not recruiting

Study on the Effectiveness and Safety of Venglustat for Adults and Children with Gaucher Disease TYPE 3

Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Imiglucerase

Fabry's disease

Not recruiting

Study of venglustat tablets to reduce neuropathic and abdominal pain in patients aged 16 and older with Fabry disease who are untreated or haven't received treatment for 6 months

Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Venglustat

Gaucher's disease type III+1

Not recruiting

Study of Venglustat and Imiglucerase for Adult Patients with Gaucher Disease TYPE 3

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Imiglucerase

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.